Table 2 A total of ten genes were found to be prognostic markers in patients with CxCa
From: Exploring molecular targets: herbal isolates in cervical cancer therapy
A. Single gene | |||
Gene symbol (gene label) | HR (high) | P (log-rank test) | P (HR) |
MYC (A) | 2 | 0.0039 | 0.0046 |
IL6 (B) | 1.7 | 0.024 | 0.026 |
JUN (C) | 1.7 | 0.027 | 0.029 |
RRM2 (D) | 1.7 | 0.029 | 0.031 |
VEGFA (E) | 1.7 | 0.032 | 0.035 |
RFC4 (F) | 0.56 | 0.014 | 0.015 |
EXO1 (G) | 0.57 | 0.018 | 0.019 |
PCNA (H) | 0.58 | 0.022 | 0.023 |
TOP2A (I) | 0.59 | 0.029 | 0.031 |
TYMS (J) | 0.62 | 0.041 | 0.044 |
B. Combination of genes | |||
Prognostic panel | HR (high) | P (log-rank test) | P (HR) |
A + B | 1.4 | 0.14 | 0.14 |
A + B + C | 1.9 | 0.029 | 0.031 |
A + B + C + D | 1.7 | 0.023 | 0.024 |
A + B + C + D + E | 1.9 | 0.0068 | 0.0079 |
F + G | 0.65 | 0.069 | 0.079 |
F + G + H | 0.59 | 0.028 | 0.03 |
F + G + H + I | 0.59 | 0.027 | 0.029 |
F + G + H + I + J | 0.53 | 0.0083 | 0.0094 |